Claim Missing Document
Check
Articles

Found 2 Documents
Search

Characteristics of Loss to Follow-Up Patient in Drug-Sensitive Pulmonary TB in Medan Sari Mardia, Rina; Sinaga, Bintang YM; Siagian, Parluhutan; Taufik, Ashar
Journal of Society Medicine Vol. 3 No. 10 (2024): Oktober
Publisher : CoinReads Media Prima

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.47353/jsocmed.v3i10.166

Abstract

Introduction: Tuberculosis (TB) is a chronic infectious disease caused by Mycobacterium tuberculosis. Adherence to TB treatment is a complex and dynamic phenomenon with various interacting factors. The characteristics of loss to follow-up patients include social, clinical, and economic characteristics. The Aim of study was to identify characteristics of loss to follow-up patients in drug-sensitive pulmonary TB in Medan. Method: This research is a descriptive study using a cross-sectional approach. All variables were measured and observed at a time during the study. The study was conducted at RSUP Adam Malik Medan and Prof. Dr. Chairuddin P. Lubis USU Hospital in loss to follow-up TB patients diagnosed bacteriologically that meet the criteria of inclusion and exclusion. This study used data from medical records and questionnaires. Independent variables include age, gender, educational level, employment, marital status, family history of lung tuberculosis, attitudes to TB treatment, social support, health services, and reasons for loss to follow-up. Results: Out of 40 patients with loss to follow-up pulmonary tuberculosis, the majority were patients in the age range of 45-65 years (n=26.65%), male (n=31.77,5%), equal level of high school education (n = 24.60%) had a fixed job (n=33.82.5%), marital status (n=33.90%), had no family history of lung tuberculosis (n=36.90%), poor attitude to TB treatment (n=36.90%), received low social support (n=51.52,5%), and received less supported health care services (n<33.82,5%). Reasons patients TB SO quit taking medication presented in this study vary, among others due to the side effects of TB drugs, patients choosing herbal drugs, already feeling healthy, laziness consuming TB medication, being embarrassed with pulmonary TB disease, not taking lung TB drugs because no one carries or has no transportation costs. Conclusion: The majority of patients with drug-sensitive pulmonary tuberculosis who quit their medication in the fields are between 46 and 65 years of age, male sex, high school graduates of equal degree, have a fixed job, marital status, have no family history of TB, have an inferior attitude to TB treatment, receive low social support, and receive less supportive health services. Reasons for loss to follow-up for SO TB patients vary, including TB drug effects, clinical, and economic.
Risk Factor of Lost to Follow-up Treatment in drug-sensitive pulmonary TB patients Sari Mardia, Rina; Yinke Magdalena Sinaga, Bintang; Siagian, Parluhutan; Ashar , Taufik
International Journal of Health and Pharmaceutical (IJHP) Vol. 5 No. 4 (2025): November 2025
Publisher : CV. Inara

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.51601/ijhp.v5i4.468

Abstract

Background: Loss to follow-up (LTFU) treatment remains a critical challenge in tuberculosis control in Indonesia, accounting for approximately 50% of treatment failure cases among pulmonary TB patients. Objectives: To identify independent predictors of LTFU among drug-sensitive TB (DS-TB) patients in Medan, Indonesia. Methods: This cross-sectional analytical study enrolled 100 DS-TB patients (40 with LTFU, 60 treatment-completed) from two hospitals. Purposive sampling technique was employed. Data were collected using validated questionnaires assessing sociodemographic characteristics, patient perspective toward TB treatment, social support (using MSPSS scale), and healthcare services quality. Bivariate analysis used chi-square and Fisher's exact tests; multivariate analysis employed multiple logistic regression. Statistical significance was set at p < 0.05. Results: Multivariate analysis identified two independent predictors of LTFU: social support (odds ratio 128.632; 95% confidence interval 13.809 to 1,198.216; p < 0.001) and treatment perspective (odds ratio 25.415; 95% confidence interval 5.569 to 115.985; p < 0.001). Low to moderate social support was the most dominant risk factor, conferring approximately 128.7 times greater odds of treatment discontinuation compared to high social support. Poor treatment perspective was the second dominant predictor, with 90% of LTFU patients demonstrating negative perspectives. Conclusion: Poor treatment perspective and low to moderate social support are significantly associated with LTFU treatment discontinuation in DS-TB patients. Psychosocial interventions addressing these factors should be prioritized in TB control programs to improve treatment completion rates and achieve WHO treatment success targets.